glp-1+gip Science Behind GLP 1 GIP and Glucagon Receptor Agonists for Obesity Research | News & Announcements GLP-1 Agonist Therapy Center -

At Josie, we offer compounded versions because they allow for personalized dosing , slower starts, and more support as your hormones shift

The molecular weight and structure of semaglutide do not exclude it from passive transfer into milk, unlike some larger antibody-based drugs that remain excluded

The results suggest that, with proper supervision, a protein-rich diet, regular resistance training, and guidance from a trained medical provider, patients can decrease fat mass while minimizing muscle loss. We found that, under close supervision and regular follow-up from an obesity medicine specialist, patients were able to lose fat mass with only a minimal decline in muscle mass, Peralta-Reich added

Research Points To Fewer Drinks Per Occasion The largest randomized trial to date was published in The Lancet in May 2026

Many patients report better medication adherence with daily tablets compared to weekly injections, leading to more consistent weight-loss results over time